Connection

Joshua Rhett to Tamoxifen

Back to Details
This is a "connection" page, showing publications Joshua Rhett has written about Tamoxifen.
Joshua Rhett
Connection Strength
0.116
Tamoxifen
  1. Targeting connexin 43 with a-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer. 2015 Apr 03; 15:296.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.